Moolec Science S.A. logo

Moolec Science S.A. (MLECW)

Market Closed
27 Jul, 20:00
NASDAQ (CM) NASDAQ (CM)
$
0. 02
0
0%
$
226.55K Market Cap
- P/E Ratio
- Div Yield
40,348 Volume
0 Eps
$ 0.02
Previous Close
Investors:
Add Transaction
Day Range
0.01 0.02
Year Range
0 0.14
Want to track MLECW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

MLECW closed today higher at $0.02, an increase of 0% from yesterday's close, completing a monthly increase of 70.6897% or $0.01. Over the past 12 months, MLECW stock gained 110.6383%.
MLECW is not paying dividends to its shareholders.
The last earnings report, released on Mar 11, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

MLECW Chart

People also search for

Inmune Bio Inc.
$ 1.73
+6.7901%
TIL
Instil Bio, Inc.
$ 7.15
+0.2805%
Atyr Pharma Inc.
$ 0.49
+3.5095%
Mereo BioPharma Group plc - ADR
$ 0.3
+4.8958%
Dyadic International Inc.
$ 1.13
-5.042%

Moolec Science S.A. Investors

Name Quantity Cost Value Profit ($) Gain (%)
BO
Brian Oliveira Clear Street Group Inc.
199,370 $1,160.17 $3,409.23 $2,249.06 193.86%
ECM
Eisler Capital Management Ltd. Eisler Capital Management Ltd.
10,931 $276 $266.72 -$9.28 -3.36%

Moolec Science S.A. (MLECW) FAQ

What is the stock price today?

The current price is $0.02.

On which exchange is it traded?

Moolec Science S.A. is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is MLECW.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 226.55K.

Has Moolec Science S.A. ever had a stock split?

No, there has never been a stock split.

Moolec Science S.A. Profile

Biotechnology Industry
Healthcare Sector
Alejandro Antalich CEO
NASDAQ (CM) Exchange
G6223S117 CUSIP
KY Country
52 Employees
- Last Dividend
3 Jan 2023 Last Split
3 Jan 2023 IPO Date

Overview

Moolec Science SA is a pioneering science-based food ingredient company, established in 2020 and headquartered in Luxembourg. It specializes in creating real animal proteins within plants through a revolutionary approach known as molecular farming. This technique allows Moolec Science to produce animal proteins efficiently and sustainably, without needing to harvest the animals themselves. The company has a robust footprint, operating across the United States, Europe, and South America, reflecting its global approach to addressing the needs of the food industry and contributing to food sustainability efforts.

Products and Services

  • Chymosin SPC - This dairy ingredient is a prime example of Moolec Science's innovation. Chymosin SPC is designed to enhance the cheese-making process, offering a plant-based alternative that mimics the functionality of traditional animal-derived chymosin.
  • GLA SONOVA - A nutritional oil that stands out for its health benefits. GLA SONOVA is rich in gamma-linolenic acid (GLA), a type of fatty acid that is often hard to obtain from the diet alone. This product underscores Moolec Science's commitment to offering products that not only substitute animal ingredients but also provide nutritional enhancements.
  • POORK+ - A cutting-edge plant-based, meat-free ingredient that incorporates porcine proteins into soybeans. POORK+ is designed to replicate the taste, texture, and nutritional profile of pork, offering a sustainable and ethical alternative for consumers looking to reduce their meat consumption.
  • BEEF+ - Expanding on the concept of meatless options, BEEF+ is a meat replacement product that aims to closely mimic the properties of beef. This product is a testament to Moolec Science's capabilities in creating plant-based alternatives that do not compromise on the experience of consuming real meat.

Contact Information

Address: 89 Nexus Way
Phone: 352 26 49 65 65